Jason Denoncourt

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Jason Denoncourt is an author at Alnylam Pharmaceuticals (United States) specializing in acinetobacter baumannii resistance, bacterial virulence genes, and antibacterial resistance.

ORCID

Publications per year

2023–2024

Publications

Genome-wide phage susceptibility analysis in Acinetobacter baumannii reveals capsule modulation strategies that determine phage infectivity

Jinna Bai, Nicole Raustad, Jason Denoncourt et al. · PLoS Pathogens · 2023 · 31 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Evaluating the oral delivery of GalNAc-conjugated siRNAs in rodents and non-human primates

Mikyung Yu, June Qin, Xiumin Liu et al. · Nucleic Acids Research · 2024 · 10 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

1–2 of 2